A leading provider of
innovative DNA Screening solutions
SRD (CHD5) Deletion Probe LPS010 - Detail
The 1p36 region is frequently deleted in a broad range of human cancers1. The Chromodomain Helicase DNA binding domain 5 (CHD5) gene acts as a tumour suppressor at 1p36 and is frequently deleted in human gliomas2, leukaemia/lymphoma3 and neuroblastoma4. Deletion of the short arm of chromosome 1 is one of the most characteristic genetic changes in neuroblastomas, a tumour of the sympathetic nervous system. This is the most common childhood extracranial solid tumour accounting for around 8%-10% of childhood cancers and 15% of childhood cancer deaths5. The CHD5 gene has been characterised as the lead tumour suppressor candidate from the 1p36 SRD (smallest region of consistent deletion) region in neuroblastoma6.
Reference:/Bibliographie/Literatur/Bibliografia
- Bagchi and Mills 2008, Canc Res 68(8):2551-56
- Bagchi et al. 2007, Cell 128(3): 459-75
- Maser et al. 2007, Nature 447:966-74
- Okawa et al. 2008, Oncogene 27:803-10
- Broudeur and Maris 2006 Neuroblastoma in Principles and Practice of Pediatric Oncology. 5th ed. Philadelphia, PA:Lippincott: 933-970
- Fujita et al 2008 J Natl Cancer Inst 100: 940-949
SRD (CHD5) Deletion Probe
Cat. No. LPS 010
This webpage could contain information on product details or information not valid in your country or region. Please be aware that we do not take any responsibility for accessing such information, which may not comply with any legal process, regulation, registration or usage in the country of your origin. If you are a resident of a country other than those to which this site is directed, contact your local Cytocell distributor to obtain the appropriate product information for your country of residence.
Developed &produced in the UK